Some experiments on mouse model and a few clinical trials on pancreatic cancer and other solid tumors demonstrated that DCs vaccines loaded with MUC1 show an effective durable response with good safe and tolerability [115]. Here, MUC1 is linked to familial pancreatic carcinoma.